IFP Advisors Inc Grows Holdings in Mettler-Toledo International, Inc. $MTD

IFP Advisors Inc grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 542.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 90 shares of the medical instruments supplier’s stock after acquiring an additional 76 shares during the period. IFP Advisors Inc’s holdings in Mettler-Toledo International were worth $106,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Greenleaf Trust increased its stake in Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock worth $1,030,000 after buying an additional 10 shares during the period. Brooklyn Investment Group increased its stake in Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock worth $104,000 after buying an additional 10 shares during the period. Sax Wealth Advisors LLC increased its stake in Mettler-Toledo International by 2.8% during the 2nd quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock worth $437,000 after buying an additional 10 shares during the period. Sequoia Financial Advisors LLC increased its stake in Mettler-Toledo International by 1.8% during the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock worth $740,000 after buying an additional 11 shares during the period. Finally, Albion Financial Group UT increased its stake in Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock worth $890,000 after buying an additional 11 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Thomas P. Salice sold 1,062 shares of the company’s stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Gerry Keller sold 165 shares of the stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider owned 94 shares of the company’s stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,827 shares of company stock worth $2,371,208. Corporate insiders own 0.77% of the company’s stock.

Mettler-Toledo International Trading Down 0.6%

Shares of Mettler-Toledo International stock opened at $1,351.15 on Monday. The company has a fifty day simple moving average of $1,287.35 and a 200-day simple moving average of $1,195.77. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,438.46. The stock has a market cap of $27.83 billion, a price-to-earnings ratio of 34.21, a PEG ratio of 4.05 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. During the same quarter in the prior year, the business posted $9.65 EPS. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on MTD shares. Bank of America upped their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Robert W. Baird upped their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Citigroup upped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Barclays boosted their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a report on Thursday, October 2nd. Finally, Evercore ISI boosted their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International presently has an average rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.